The empty intravenous (iv) bags market size has grown rapidly in recent years. It will grow from $7.15 billion in 2025 to $8.08 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to growth in hospital admissions, increasing use of intravenous therapies, expansion of healthcare infrastructure, rising prevalence of chronic diseases, widespread adoption of iv drug administration.
The empty intravenous (iv) bags market size is expected to see rapid growth in the next few years. It will grow to $12.51 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing demand for infusion-based treatments, growing aging population, rising surgical and critical care procedures, expansion of outpatient and clinic-based care, increasing preference for safer iv packaging materials. Major trends in the forecast period include growing shift toward non-pvc intravenous bags, rising demand for multi-chamber iv bag configurations, increasing use of iv bags in critical and acute care settings, expansion of ready-to-mix and customized iv solutions, rising focus on sterility and contamination prevention.
The increasing number of surgical procedures is expected to drive the growth of the empty intravenous (IV) bag market in the future. Surgical procedures are medical treatments that involve invasive techniques to treat or correct health conditions, injuries, or abnormalities within the body. The rise in surgical procedures can be attributed to advancements in medical technology, an aging population, the growing prevalence of chronic diseases, better access to healthcare, and higher patient expectations. Empty intravenous (IV) bags are crucial in delivering essential fluids, medications, blood products, and anesthesia support during surgeries. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, in 2023, the number of plastic surgeries grew by 5%, while minimally invasive procedures increased by 7% compared to 2022. As a result, the increasing number of surgical procedures is contributing to the growth of the empty intravenous (IV) bag market.
The high prevalence of chronic diseases is anticipated to fuel the growth of the empty IV bags market. Chronic diseases, which persist over an extended period and often require lifelong management, are on the rise due to factors such as aging populations, lifestyle changes, urbanization, obesity, healthcare access, stress, and mental health issues. Empty IV bags are crucial for preparing and administering personalized medication solutions, supporting home infusion therapy, providing nutrition and hydration, and facilitating palliative care. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93% among older adults. Therefore, the high prevalence of chronic diseases is driving the growth of the empty intravenous (IV) bag market.
Major companies in the empty intravenous (IV) bags market are focusing on advancing the recycling of IV bags by developing sustainable methods for collection, processing, and repurposing. These efforts aim to minimize environmental impact and promote circular economy practices in the healthcare industry. Advancing IV bag recycling involves enhancing processes and systems to recycle used IV bags, which are typically made from plastic materials such as polyvinyl chloride (PVC) or other recyclable polymers. For example, in December 2023, Baxter International Inc., a US-based healthcare company, launched the first IV bag recycling pilot program in the United States in collaboration with Northwestern Medicine. This initiative seeks to tackle the environmental issues associated with single-use plastic IV bags, which are often discarded in landfills after use.
Major companies operating in the empty intravenous (iv) bags market are Fresenius Medical Care AG KGaA, Becton Dickinson and Company, Amcor LLC, Baxter International Inc., Grifols S.A., Hospira Inc., Nipro Corporation, B. Braun Medical Inc., ICU Medical Inc., RENOLIT Healthcare, Kiefel GmbH, BAUSCH Advanced Technology Group, Technoflex, Sippex IV bags, AdvaCare Pharma Limited, Tacy Medical Inc., Polycine GmbH, JW Life Science Corp, Mitra Industries Private Limited, Terumo Corporation.
North America was the largest region in the empty intravenous (IV) bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the empty intravenous (iv) bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the empty intravenous (iv) bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the empty intravenous (iv) bags market by increasing costs for imported polymers, resins, and medical-grade plastic components used in bag manufacturing. These impacts are most visible across non-pvc and multi-chamber iv bag segments, particularly in hospitals and clinics within regions dependent on global raw material supply chains such as asia-pacific and europe. Higher tariffs have moderately raised production and procurement costs for healthcare providers. However, tariffs are also encouraging local sourcing of materials, regional manufacturing expansion, and investments in alternative materials, supporting long-term supply resilience.
The empty intravenous (iv) bags market research report is one of a series of new reports that provides empty intravenous (iv) bags market statistics, including empty intravenous (iv) bags industry global market size, regional shares, competitors with a empty intravenous (iv) bags market share, detailed empty intravenous (iv) bags market segments, market trends and opportunities, and any further data you may need to thrive in the empty intravenous (iv) bags industry. This empty intravenous (iv) bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Empty intravenous (IV) bags serve as sterile, flexible containers intended for the direct administration of fluids, medications, or nutrients into a patient's bloodstream. These bags are essential in medical settings for the preparation and delivery of IV solutions, available in various sizes and materials, often equipped with ports for easy connection to IV lines and infusion sets.
The primary types of empty intravenous (IV) bags include single-chamber and dual-chamber varieties. A single-chamber empty IV bag is a sterile container used for preparing and administering fluids or medications intravenously, typically featuring a single compartment. These products are available in polyvinyl chloride and non-polyvinyl chloride variants, constructed from materials such as polypropylene, polyester ether, ethylene vinyl acetate, among others, offering capacities ranging from 50 ml to 100 ml, 100 ml to 250 ml, 250 ml to 500 ml, and above 500 ml. These bags find applications primarily in hospitals, clinics, and other medical settings.
The empty intravenous (IV) bags market consists of sales of sterile IV bags, pressure-resistant bags, and light-protective bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The empty intravenous (iv) bags market size is expected to see rapid growth in the next few years. It will grow to $12.51 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing demand for infusion-based treatments, growing aging population, rising surgical and critical care procedures, expansion of outpatient and clinic-based care, increasing preference for safer iv packaging materials. Major trends in the forecast period include growing shift toward non-pvc intravenous bags, rising demand for multi-chamber iv bag configurations, increasing use of iv bags in critical and acute care settings, expansion of ready-to-mix and customized iv solutions, rising focus on sterility and contamination prevention.
The increasing number of surgical procedures is expected to drive the growth of the empty intravenous (IV) bag market in the future. Surgical procedures are medical treatments that involve invasive techniques to treat or correct health conditions, injuries, or abnormalities within the body. The rise in surgical procedures can be attributed to advancements in medical technology, an aging population, the growing prevalence of chronic diseases, better access to healthcare, and higher patient expectations. Empty intravenous (IV) bags are crucial in delivering essential fluids, medications, blood products, and anesthesia support during surgeries. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, in 2023, the number of plastic surgeries grew by 5%, while minimally invasive procedures increased by 7% compared to 2022. As a result, the increasing number of surgical procedures is contributing to the growth of the empty intravenous (IV) bag market.
The high prevalence of chronic diseases is anticipated to fuel the growth of the empty IV bags market. Chronic diseases, which persist over an extended period and often require lifelong management, are on the rise due to factors such as aging populations, lifestyle changes, urbanization, obesity, healthcare access, stress, and mental health issues. Empty IV bags are crucial for preparing and administering personalized medication solutions, supporting home infusion therapy, providing nutrition and hydration, and facilitating palliative care. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93% among older adults. Therefore, the high prevalence of chronic diseases is driving the growth of the empty intravenous (IV) bag market.
Major companies in the empty intravenous (IV) bags market are focusing on advancing the recycling of IV bags by developing sustainable methods for collection, processing, and repurposing. These efforts aim to minimize environmental impact and promote circular economy practices in the healthcare industry. Advancing IV bag recycling involves enhancing processes and systems to recycle used IV bags, which are typically made from plastic materials such as polyvinyl chloride (PVC) or other recyclable polymers. For example, in December 2023, Baxter International Inc., a US-based healthcare company, launched the first IV bag recycling pilot program in the United States in collaboration with Northwestern Medicine. This initiative seeks to tackle the environmental issues associated with single-use plastic IV bags, which are often discarded in landfills after use.
Major companies operating in the empty intravenous (iv) bags market are Fresenius Medical Care AG KGaA, Becton Dickinson and Company, Amcor LLC, Baxter International Inc., Grifols S.A., Hospira Inc., Nipro Corporation, B. Braun Medical Inc., ICU Medical Inc., RENOLIT Healthcare, Kiefel GmbH, BAUSCH Advanced Technology Group, Technoflex, Sippex IV bags, AdvaCare Pharma Limited, Tacy Medical Inc., Polycine GmbH, JW Life Science Corp, Mitra Industries Private Limited, Terumo Corporation.
North America was the largest region in the empty intravenous (IV) bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the empty intravenous (iv) bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the empty intravenous (iv) bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the empty intravenous (iv) bags market by increasing costs for imported polymers, resins, and medical-grade plastic components used in bag manufacturing. These impacts are most visible across non-pvc and multi-chamber iv bag segments, particularly in hospitals and clinics within regions dependent on global raw material supply chains such as asia-pacific and europe. Higher tariffs have moderately raised production and procurement costs for healthcare providers. However, tariffs are also encouraging local sourcing of materials, regional manufacturing expansion, and investments in alternative materials, supporting long-term supply resilience.
The empty intravenous (iv) bags market research report is one of a series of new reports that provides empty intravenous (iv) bags market statistics, including empty intravenous (iv) bags industry global market size, regional shares, competitors with a empty intravenous (iv) bags market share, detailed empty intravenous (iv) bags market segments, market trends and opportunities, and any further data you may need to thrive in the empty intravenous (iv) bags industry. This empty intravenous (iv) bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Empty intravenous (IV) bags serve as sterile, flexible containers intended for the direct administration of fluids, medications, or nutrients into a patient's bloodstream. These bags are essential in medical settings for the preparation and delivery of IV solutions, available in various sizes and materials, often equipped with ports for easy connection to IV lines and infusion sets.
The primary types of empty intravenous (IV) bags include single-chamber and dual-chamber varieties. A single-chamber empty IV bag is a sterile container used for preparing and administering fluids or medications intravenously, typically featuring a single compartment. These products are available in polyvinyl chloride and non-polyvinyl chloride variants, constructed from materials such as polypropylene, polyester ether, ethylene vinyl acetate, among others, offering capacities ranging from 50 ml to 100 ml, 100 ml to 250 ml, 250 ml to 500 ml, and above 500 ml. These bags find applications primarily in hospitals, clinics, and other medical settings.
The empty intravenous (IV) bags market consists of sales of sterile IV bags, pressure-resistant bags, and light-protective bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Empty Intravenous (IV) Bags Market Characteristics
3. Empty Intravenous (IV) Bags Market Supply Chain Analysis
4. Global Empty Intravenous (IV) Bags Market Trends and Strategies
5. Empty Intravenous (IV) Bags Market Analysis of End Use Industries
7. Global Empty Intravenous (IV) Bags Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Empty Intravenous (IV) Bags Total Addressable Market (TAM) Analysis for the Market
9. Empty Intravenous (IV) Bags Market Segmentation
50 ML - 100 ML, 100 ML - 250 ML, 250 ML - 500 ML, Above 500 ML
10. Empty Intravenous (IV) Bags Market Regional and Country Analysis
11. Asia-Pacific Empty Intravenous (IV) Bags Market
12. China Empty Intravenous (IV) Bags Market
13. India Empty Intravenous (IV) Bags Market
14. Japan Empty Intravenous (IV) Bags Market
15. Australia Empty Intravenous (IV) Bags Market
16. Indonesia Empty Intravenous (IV) Bags Market
17. South Korea Empty Intravenous (IV) Bags Market
18. Taiwan Empty Intravenous (IV) Bags Market
19. South East Asia Empty Intravenous (IV) Bags Market
20. Western Europe Empty Intravenous (IV) Bags Market
21. UK Empty Intravenous (IV) Bags Market
22. Germany Empty Intravenous (IV) Bags Market
23. France Empty Intravenous (IV) Bags Market
24. Italy Empty Intravenous (IV) Bags Market
25. Spain Empty Intravenous (IV) Bags Market
26. Eastern Europe Empty Intravenous (IV) Bags Market
27. Russia Empty Intravenous (IV) Bags Market
28. North America Empty Intravenous (IV) Bags Market
29. USA Empty Intravenous (IV) Bags Market
30. Canada Empty Intravenous (IV) Bags Market
31. South America Empty Intravenous (IV) Bags Market
32. Brazil Empty Intravenous (IV) Bags Market
33. Middle East Empty Intravenous (IV) Bags Market
34. Africa Empty Intravenous (IV) Bags Market
36. Empty Intravenous (IV) Bags Market Competitive Landscape and Company Profiles
37. Empty Intravenous (IV) Bags Market Other Major and Innovative Companies
40. Empty Intravenous (IV) Bags Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Empty Intravenous (IV) Bags Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses empty intravenous (iv) bags market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for empty intravenous (iv) bags? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The empty intravenous (iv) bags market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Polyvinyl Chloride; Non-Polyvinyl Chloride2) By Chamber Configuration: Single Chamber; Multi-Chamber
3) By Material: Polypropylene; Polyester Ether; Ethylene Vinyl Acetate (EVA); Other Materials
4) By Capacity: 50 ML - 100 ML; 100 ML - 250 ML; 250 ML - 500 ML; Above 500 ML
5) By Application: Hospital; Clinic; Other Applications
Subsegments:
1) By Polyvinyl Chloride (PVC): Flexible PVC IV Bags; Rigid PVC IV Bags2) By Non-Polyvinyl Chloride (Non-PVC): Ethylene Vinyl Acetate (EVA) IV Bags; Other Non-PVC Materials
Companies Mentioned: Fresenius Medical Care AG KGaA; Becton Dickinson and Company; Amcor LLC; Baxter International Inc.; Grifols S.A.; Hospira Inc.; Nipro Corporation; B. Braun Medical Inc.; ICU Medical Inc.; RENOLIT Healthcare; Kiefel GmbH; BAUSCH Advanced Technology Group; Technoflex; Sippex IV bags; AdvaCare Pharma Limited; Tacy Medical Inc.; Polycine GmbH; JW Life Science Corp; Mitra Industries Private Limited; Terumo Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Empty Intravenous (IV) Bags market report include:- Fresenius Medical Care AG KGaA
- Becton Dickinson and Company
- Amcor LLC
- Baxter International Inc.
- Grifols S.A.
- Hospira Inc.
- Nipro Corporation
- B. Braun Medical Inc.
- ICU Medical Inc.
- RENOLIT Healthcare
- Kiefel GmbH
- BAUSCH Advanced Technology Group
- Technoflex
- Sippex IV bags
- AdvaCare Pharma Limited
- Tacy Medical Inc.
- Polycine GmbH
- JW Life Science Corp
- Mitra Industries Private Limited
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.08 Billion |
| Forecasted Market Value ( USD | $ 12.51 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
